why do pbms have different rules for glp-1 coverage How to Find a Health Plan That Covers Medications Like Wegovy & Ozempic February 9, 2026: PBMs are

Announcement Declares Injectable Glucagon-like Peptide-1 (GLP-1) Drugs as Specially Controlled Substances Share The Ministry of Public Health has announced that injectable Glucagon-like Peptide-1 (GLP-1) drugs will be classified as specially controlled substances, effective 180 days after the day following the announcement's publication in the Government Gazette

The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent

Data from the OASIS 4 (oral semaglutide) and STEP 5 (injectable semaglutide) trials highlight similar outcomes across key endpoints

More frequent monitoring is prudent